Gabrielle Masson
@gabriellemasson.bsky.social
Senior Editor of Fierce Biotech | As read in Lily Poetry Review & Eunoia Review
Reposted by Gabrielle Masson
Biogen could have stripped HI-Bio for parts when it bought the biotech for $1.15 billion last year--instead, it used the California company as a foundation to build a brand new, immunology-focused West Coast Hub. I've got the details here! 🧪💊
How Biogen is returning to its roots with a West Coast immunology outpost
On its face, Biogen’s May 2024 acquisition of Human Immunology Biosciences (HI-Bio) | On its face, there wasn’t much notable about Biogen’s May 2024 acquisition of Human Immunology Biosciences (HI-Bio...
www.fiercebiotech.com
November 18, 2025 at 5:51 PM
Biogen could have stripped HI-Bio for parts when it bought the biotech for $1.15 billion last year--instead, it used the California company as a foundation to build a brand new, immunology-focused West Coast Hub. I've got the details here! 🧪💊
Reposted by Gabrielle Masson
Cuts to NIH grants have disrupted at least 383 clinical trials, with infectious disease research hit especially hard. A stark example of the real-world repercussions of Trump and co.'s health policy 🧪 my latest:
NIH grant cuts have disrupted hundreds of clinical trials, study finds
The second Trump administration has been defined by widespread cuts to federal spending, including at the National Institutes of Health (NIH). | The second Trump administration has been defined by wid...
www.fiercebiotech.com
November 17, 2025 at 4:24 PM
Cuts to NIH grants have disrupted at least 383 clinical trials, with infectious disease research hit especially hard. A stark example of the real-world repercussions of Trump and co.'s health policy 🧪 my latest:
Reposted by Gabrielle Masson
Biotechs beware: you're in for a scare.
Had a blast writing this year's edition of the Biotech Graveyard, a terrifying Fierce Biotech tradition where we honor the ghosts of biotechs past and also allude to the 1958 novelty song "The Purple People Eater." Give it a read--if you dare!
Had a blast writing this year's edition of the Biotech Graveyard, a terrifying Fierce Biotech tradition where we honor the ghosts of biotechs past and also allude to the 1958 novelty song "The Purple People Eater." Give it a read--if you dare!
The 2025 Biotech Graveyard
Reader, beware: You’re entering haunted grounds. | This year’s list features 16 biotechs that have shut down and another three that have one foot in the grave.
www.fiercebiotech.com
October 31, 2025 at 5:22 PM
Biotechs beware: you're in for a scare.
Had a blast writing this year's edition of the Biotech Graveyard, a terrifying Fierce Biotech tradition where we honor the ghosts of biotechs past and also allude to the 1958 novelty song "The Purple People Eater." Give it a read--if you dare!
Had a blast writing this year's edition of the Biotech Graveyard, a terrifying Fierce Biotech tradition where we honor the ghosts of biotechs past and also allude to the 1958 novelty song "The Purple People Eater." Give it a read--if you dare!
Reposted by Gabrielle Masson
About 30 years after their discovery, Nobel-winning regulatory T cells are on the cusp of becoming new medicines; and as one of this year's laureates told me, they have the potential to become a "universal drug" 🧪 my deep dive into Tregs:
Panacea potential: How Nobel-winning regulatory T cells could become a ‘universal drug’
While presenting this year’s Nobel Prize in Physiology or Medicine to three immunologists who
www.fiercebiotech.com
October 21, 2025 at 5:34 PM
About 30 years after their discovery, Nobel-winning regulatory T cells are on the cusp of becoming new medicines; and as one of this year's laureates told me, they have the potential to become a "universal drug" 🧪 my deep dive into Tregs:
When it comes to China tariffs and limiting licenses to innovation from the country, Nkarta CEO Paul Hastings is urging the Trump administration to “let that one go."
Read more from my interview here ⬇️
Read more from my interview here ⬇️
‘We can have TikTok. Why can’t we have drugs?’: Nkarta CEO Hastings warns against China biotech penalties
As geopolitical tensions rise, Nkarta CEO Paul Hastings is urging the U.S. | As geopolitical tensions rise, Nkarta CEO Paul Hastings is urging the U.S. government not to impose restrictions on Chinese...
www.fiercebiotech.com
October 17, 2025 at 12:50 PM
When it comes to China tariffs and limiting licenses to innovation from the country, Nkarta CEO Paul Hastings is urging the Trump administration to “let that one go."
Read more from my interview here ⬇️
Read more from my interview here ⬇️
The FDA has handed out its first national priority vouchers, positioning 9 companies to complete the approval process in one to two months. www.fiercebiotech.com/biotech/fda-...
FDA names 9 first recipients of 1- to 2-month priority review vouchers
The FDA has handed out the first nine national priori | The FDA has handed out the first nine national priority vouchers, positioning companies including Merck KGaA, Regeneron and Sanofi to complete t...
www.fiercebiotech.com
October 17, 2025 at 12:33 PM
The FDA has handed out its first national priority vouchers, positioning 9 companies to complete the approval process in one to two months. www.fiercebiotech.com/biotech/fda-...
Reposted by Gabrielle Masson
An extremely common drug used to treat diabetes was able to soothe brain inflammation in female mice with multiple sclerosis, suggesting it could be a ready treatment option for a vexing disease that disproportionally affects people with female sex chromosomes 🧪 my story:
Common diabetes drug alleviates brain inflammation in female mice with multiple sclerosis
A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the long-used medicine could be
www.fiercebiotech.com
October 16, 2025 at 2:35 PM
An extremely common drug used to treat diabetes was able to soothe brain inflammation in female mice with multiple sclerosis, suggesting it could be a ready treatment option for a vexing disease that disproportionally affects people with female sex chromosomes 🧪 my story:
Reposted by Gabrielle Masson
The most complicated story I've ever worked on has dropped.
It's long and worth the read.
I go deep into the world of alternative funding programs & how they're harming patient access to timely prescriptions:
www.fiercehealthcare.com/payers/new-w...
It's long and worth the read.
I go deep into the world of alternative funding programs & how they're harming patient access to timely prescriptions:
www.fiercehealthcare.com/payers/new-w...
A new wave of middlemen offers 'alternative funding' for specialty drugs. Patients bear the risks
As someone living with cardiac sarcoidosis, 60-year-old Kevin Danahy can’t afford to have bad health insurance. | Alternative funding programs claim to help self-insured employers save money on specia...
www.fiercehealthcare.com
October 15, 2025 at 3:54 PM
The most complicated story I've ever worked on has dropped.
It's long and worth the read.
I go deep into the world of alternative funding programs & how they're harming patient access to timely prescriptions:
www.fiercehealthcare.com/payers/new-w...
It's long and worth the read.
I go deep into the world of alternative funding programs & how they're harming patient access to timely prescriptions:
www.fiercehealthcare.com/payers/new-w...
Reposted by Gabrielle Masson
Emerging from the darkness of this era will require us to acknowledge that the previous status quo, including many institutions that may have served us well in another era, have been failing for my entire lifetime.
October 15, 2025 at 3:45 PM
Emerging from the darkness of this era will require us to acknowledge that the previous status quo, including many institutions that may have served us well in another era, have been failing for my entire lifetime.
Reposted by Gabrielle Masson
Greg Bovino, Kristi Noem, and DHS need to answer for their unchecked attacks on Chicago residents.
ICE is an out-of-control danger to our peaceful communities.
The images from the Sun-Times today speak for themselves.
ICE is an out-of-control danger to our peaceful communities.
The images from the Sun-Times today speak for themselves.
October 15, 2025 at 12:30 AM
Greg Bovino, Kristi Noem, and DHS need to answer for their unchecked attacks on Chicago residents.
ICE is an out-of-control danger to our peaceful communities.
The images from the Sun-Times today speak for themselves.
ICE is an out-of-control danger to our peaceful communities.
The images from the Sun-Times today speak for themselves.
Reposted by Gabrielle Masson
The 2025 Nobel Prize in Physiology or Medicine is here and it's a doozy: the discovery of regulatory T cells! I woke up at 2am to write this story so if you see any typos, no you didn't:
3 immunologists win Nobel Prize in Physiology or Medicine for discovery of regulatory T cells
The 2025 Nobel Prize in Physiology or Medicine has been awarded to three pioneering immunologists for their work on regu | The 2025 Nobel Prize in Physiology or Medicine has been awarded to three pion...
www.fiercebiotech.com
October 6, 2025 at 11:28 AM
The 2025 Nobel Prize in Physiology or Medicine is here and it's a doozy: the discovery of regulatory T cells! I woke up at 2am to write this story so if you see any typos, no you didn't:
If the university is found in violation of civil rights laws, a "debarment" would prohibit the university from business relations with any federal agency for a specified timeframe. www.fiercebiotech.com/biotech/hhs-...
HHS division refers Harvard for potential debarment as funding clash takes new form
After Harvard University scored a recent legal victory ov | After Harvard University scored a recent legal victory over the Trump administration's “arbitrary and capricious" funding freeze orders, it ...
www.fiercebiotech.com
September 29, 2025 at 9:07 PM
If the university is found in violation of civil rights laws, a "debarment" would prohibit the university from business relations with any federal agency for a specified timeframe. www.fiercebiotech.com/biotech/hhs-...
Reposted by Gabrielle Masson
To understand how budget cuts could impact the NIH, economists looked to the past--and their alternate history revealed how Trump-level defunding would have undercut breakthrough new medicines of the 21st century 🧪 my story:
'Alternative history' of the NIH shows how a 40% budget cut may thwart new medicines
An “alternative history” has revealed the potential impacts a smaller National Institutes of Health would have had on past drug development—and the results
www.fiercebiotech.com
September 25, 2025 at 6:01 PM
To understand how budget cuts could impact the NIH, economists looked to the past--and their alternate history revealed how Trump-level defunding would have undercut breakthrough new medicines of the 21st century 🧪 my story:
After a tumultuous journey filled with delays and rejection, the FDA has approved Stealth BioTherapeutics’ treatment for the ultrarare disease Barth syndrome, marking the peptide as the first therapy for the condition.
FDA greenlights Stealth Bio’s injection as 1st treatment for Barth syndrome
After a tumultuous journey filled with delays and rejection, the FDA has approved Stealth BioTherapeutics’ treatment for the ultrarare disease Barth syndrome, marking the peptide as the first thera | ...
www.fiercepharma.com
September 19, 2025 at 10:05 PM
After a tumultuous journey filled with delays and rejection, the FDA has approved Stealth BioTherapeutics’ treatment for the ultrarare disease Barth syndrome, marking the peptide as the first therapy for the condition.
NIH-sponsored research was the basis of all 356 new drug approvals between 2010 and 2019, according to a new AAMC report.
Here, I take a look at the states most impacted by NIH research cuts, plus the domino effects on clinical trials, the economy and public health.
Here, I take a look at the states most impacted by NIH research cuts, plus the domino effects on clinical trials, the economy and public health.
What we know about the financial impact of NIH cuts at a state level—and what it could mean for public health
As the financial ramifications of federal research cuts come into focus, several organizations are warning of the looming threat to Americans’ health. | As the financial ramifications of federal resea...
www.fiercebiotech.com
September 18, 2025 at 3:35 PM
NIH-sponsored research was the basis of all 356 new drug approvals between 2010 and 2019, according to a new AAMC report.
Here, I take a look at the states most impacted by NIH research cuts, plus the domino effects on clinical trials, the economy and public health.
Here, I take a look at the states most impacted by NIH research cuts, plus the domino effects on clinical trials, the economy and public health.
Reposted by Gabrielle Masson
Vaccines work. Period.
September 12, 2025 at 2:13 PM
Vaccines work. Period.
Reposted by Gabrielle Masson
The problem with allowing guns everywhere is that no one is safe anywhere.
September 10, 2025 at 8:24 PM
The problem with allowing guns everywhere is that no one is safe anywhere.
Reposted by Gabrielle Masson
Had a blast visiting the Knight Cancer Institute in Portland to talk about their record-setting $2 billion gift from Nike founder Phil Knight, and how they plan to use the cash to become a household name in cancer research and care. Check it out, and enjoy the photo quality from my ancient iPhone!
With 'breathtaking' $2B gift, Oregon’s Knight Cancer Institute tightens laces for race to the top
What’s the best way to spend $2 billion? | What’s the best way to spend $2 billion? That’s the pleasant problem facing oncology legend Brian Druker, M.D., as he stewards what is thought to be the larg...
www.fiercebiotech.com
September 10, 2025 at 6:13 PM
Had a blast visiting the Knight Cancer Institute in Portland to talk about their record-setting $2 billion gift from Nike founder Phil Knight, and how they plan to use the cash to become a household name in cancer research and care. Check it out, and enjoy the photo quality from my ancient iPhone!
Wellcome Leap and Melinda French Gates' Pivotal are investing $100 million in women's health breakthroughs for areas like cardiovascular, autoimmune and mental health.
Time to ‘stop tolerating women’s pain and suffering’: Melinda Gates-backed research initiative raises $100M
U.S. | U.S. nonprofit Wellcome Leap is partnering with the Melinda French Gates-founded coalition Pivotal, raising $100 million to advance women’s health research in areas with the highest need.
www.fiercebiotech.com
September 10, 2025 at 3:17 PM
Wellcome Leap and Melinda French Gates' Pivotal are investing $100 million in women's health breakthroughs for areas like cardiovascular, autoimmune and mental health.
Reposted by Gabrielle Masson
Today, I was joined by organizations representing 100,000 doctors & medical experts.
They know — I know — that vaccines work, and have saved millions of lives.
We cannot allow Sec. Kennedy or anyone else to undermine faith in science and put the health of our children at risk.
They know — I know — that vaccines work, and have saved millions of lives.
We cannot allow Sec. Kennedy or anyone else to undermine faith in science and put the health of our children at risk.
September 9, 2025 at 3:37 PM
Today, I was joined by organizations representing 100,000 doctors & medical experts.
They know — I know — that vaccines work, and have saved millions of lives.
We cannot allow Sec. Kennedy or anyone else to undermine faith in science and put the health of our children at risk.
They know — I know — that vaccines work, and have saved millions of lives.
We cannot allow Sec. Kennedy or anyone else to undermine faith in science and put the health of our children at risk.
Reposted by Gabrielle Masson
Can anyone get a Covid shot if they want one? The answer, in short, is no.
www.statnews.com/2025/09/04/c...
www.statnews.com/2025/09/04/c...
Can anyone get a Covid shot if they want one? No
Can anyone get a Covid shot if they want one? It's not that simple.
www.statnews.com
September 4, 2025 at 11:09 PM
Can anyone get a Covid shot if they want one? The answer, in short, is no.
www.statnews.com/2025/09/04/c...
www.statnews.com/2025/09/04/c...
Reposted by Gabrielle Masson
We need an HHS Secretary who respects science and does not make policy based on conspiracy theories.
Vaccines are safe and effective.
Kennedy is threatening the health of our kids and all Americans.
He must resign.
Vaccines are safe and effective.
Kennedy is threatening the health of our kids and all Americans.
He must resign.
September 4, 2025 at 7:59 PM
We need an HHS Secretary who respects science and does not make policy based on conspiracy theories.
Vaccines are safe and effective.
Kennedy is threatening the health of our kids and all Americans.
He must resign.
Vaccines are safe and effective.
Kennedy is threatening the health of our kids and all Americans.
He must resign.
Reposted by Gabrielle Masson
The Trump administration has canceled the Biden era rule where airlines would have to compensate passengers for flight disruptions.
September 4, 2025 at 8:00 PM
The Trump administration has canceled the Biden era rule where airlines would have to compensate passengers for flight disruptions.
Reposted by Gabrielle Masson
Breaking News: In a win for Harvard University, a judge said that the government broke the law by freezing billions of dollars in research funds.
Judge Issues Ruling Helpful to Harvard in Case Against Trump
Harvard had sued the Trump administration in an effort to restore billions in research funds that the government canceled this spring.
nyti.ms
September 3, 2025 at 8:42 PM
Breaking News: In a win for Harvard University, a judge said that the government broke the law by freezing billions of dollars in research funds.
Industry vets Clive Meanwell and John Maraganore have unveiled Corsera Health, a new biotech with a once-annual preventive heart disease candidate and AI risk-predicting tool.
“Imagine a world without cardiovascular disease. That's what we're aiming to do,” Maraganore told Fierce Biotech.
“Imagine a world without cardiovascular disease. That's what we're aiming to do,” Maraganore told Fierce Biotech.
Aiming to disrupt the cardiovascular space, 2 industry vets unveil Boston biotech with preventive RNAi asset
Industry giants Clive Meanwell, M.D., and John Maraganore, Ph.D., have unveiled Corsera Health, a new biotech aiming to disrupt the cardiovascular landsc | Industry giants Clive Meanwell and John Mara...
www.fiercebiotech.com
September 2, 2025 at 2:21 PM
Industry vets Clive Meanwell and John Maraganore have unveiled Corsera Health, a new biotech with a once-annual preventive heart disease candidate and AI risk-predicting tool.
“Imagine a world without cardiovascular disease. That's what we're aiming to do,” Maraganore told Fierce Biotech.
“Imagine a world without cardiovascular disease. That's what we're aiming to do,” Maraganore told Fierce Biotech.